ARCHIVES

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

This article is from The Cancer Letter archive.

Vol. 37 No. 22 | June 3, 2011

Download PDF Visit The Full Archive

Related Articles

New Therapeutic Approaches Improve Palliative Care

June 27, 2003

Obesity At Prostate-Cancer Diagnosis Increases Risk

March 30, 2007

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012

Alternative Medicine Officer Awards 30 Research Grants

October 15, 1993

Cancer Deaths In Black Men Could Drop By Cutting Tobacco

April 30, 2004

IARC Finds Limited Evidence That Residential Magnetic Fields Raise Leukemia Risk.

June 29, 2001